Non-contraceptive oestrogens and the risk of breast cancer in women

C. la Vecchia, A. Decarli, F. Parazzini, A. Gentile, C. Liberati, S. Franceschi

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The relationship between use of non-contraceptive oestrogens and risk of breast cancer was investigated using data from a hospital-based case-control study from Northern Italy. This study covered 1,108 patients with histologically confirmed breast cancers and 1,281 control subjects with a large spectrum of acute conditions unrelated to any of the known or suspected risk factors for breast cancer. Compared with 'never-users', the age-adjusted relative risk for 'ever-users' was 1.93 (95% confidence interval = 1.35-2.75). The risk increased with duration of use (relative risk = 2.08 for over 2 years), but was unrelated to time elapsed since first or last use. Allowance for a large number of identified potential confounding factors, including indicators of socio-economic status and the major determinants of breast cancer risk, failed to account for the observed association (multivariate relative risk = 1.84 for ever use and 2.04 > 2 year use). Possible explanations for these findings and for their apparent discrepancy with some American data are discussed in terms of different baseline incidence of breast cancer in the two populations, and hence of potential baseline differences in availability of endogenous serum oestrogens. Nonetheless, the results of this study should be interpreted cautiously and viewed as a further contribution to a topic still open to debate.

Original languageEnglish
Pages (from-to)853-858
Number of pages6
JournalInternational Journal of Cancer
Volume38
Issue number6
Publication statusPublished - 1986

Fingerprint

Estrogens
Breast Neoplasms
Italy
Case-Control Studies
Economics
Confidence Intervals
Incidence
Serum
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

la Vecchia, C., Decarli, A., Parazzini, F., Gentile, A., Liberati, C., & Franceschi, S. (1986). Non-contraceptive oestrogens and the risk of breast cancer in women. International Journal of Cancer, 38(6), 853-858.

Non-contraceptive oestrogens and the risk of breast cancer in women. / la Vecchia, C.; Decarli, A.; Parazzini, F.; Gentile, A.; Liberati, C.; Franceschi, S.

In: International Journal of Cancer, Vol. 38, No. 6, 1986, p. 853-858.

Research output: Contribution to journalArticle

la Vecchia, C, Decarli, A, Parazzini, F, Gentile, A, Liberati, C & Franceschi, S 1986, 'Non-contraceptive oestrogens and the risk of breast cancer in women', International Journal of Cancer, vol. 38, no. 6, pp. 853-858.
la Vecchia C, Decarli A, Parazzini F, Gentile A, Liberati C, Franceschi S. Non-contraceptive oestrogens and the risk of breast cancer in women. International Journal of Cancer. 1986;38(6):853-858.
la Vecchia, C. ; Decarli, A. ; Parazzini, F. ; Gentile, A. ; Liberati, C. ; Franceschi, S. / Non-contraceptive oestrogens and the risk of breast cancer in women. In: International Journal of Cancer. 1986 ; Vol. 38, No. 6. pp. 853-858.
@article{f46deaa2dbff4d05a53ea89e8f175e62,
title = "Non-contraceptive oestrogens and the risk of breast cancer in women",
abstract = "The relationship between use of non-contraceptive oestrogens and risk of breast cancer was investigated using data from a hospital-based case-control study from Northern Italy. This study covered 1,108 patients with histologically confirmed breast cancers and 1,281 control subjects with a large spectrum of acute conditions unrelated to any of the known or suspected risk factors for breast cancer. Compared with 'never-users', the age-adjusted relative risk for 'ever-users' was 1.93 (95{\%} confidence interval = 1.35-2.75). The risk increased with duration of use (relative risk = 2.08 for over 2 years), but was unrelated to time elapsed since first or last use. Allowance for a large number of identified potential confounding factors, including indicators of socio-economic status and the major determinants of breast cancer risk, failed to account for the observed association (multivariate relative risk = 1.84 for ever use and 2.04 > 2 year use). Possible explanations for these findings and for their apparent discrepancy with some American data are discussed in terms of different baseline incidence of breast cancer in the two populations, and hence of potential baseline differences in availability of endogenous serum oestrogens. Nonetheless, the results of this study should be interpreted cautiously and viewed as a further contribution to a topic still open to debate.",
author = "{la Vecchia}, C. and A. Decarli and F. Parazzini and A. Gentile and C. Liberati and S. Franceschi",
year = "1986",
language = "English",
volume = "38",
pages = "853--858",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Non-contraceptive oestrogens and the risk of breast cancer in women

AU - la Vecchia, C.

AU - Decarli, A.

AU - Parazzini, F.

AU - Gentile, A.

AU - Liberati, C.

AU - Franceschi, S.

PY - 1986

Y1 - 1986

N2 - The relationship between use of non-contraceptive oestrogens and risk of breast cancer was investigated using data from a hospital-based case-control study from Northern Italy. This study covered 1,108 patients with histologically confirmed breast cancers and 1,281 control subjects with a large spectrum of acute conditions unrelated to any of the known or suspected risk factors for breast cancer. Compared with 'never-users', the age-adjusted relative risk for 'ever-users' was 1.93 (95% confidence interval = 1.35-2.75). The risk increased with duration of use (relative risk = 2.08 for over 2 years), but was unrelated to time elapsed since first or last use. Allowance for a large number of identified potential confounding factors, including indicators of socio-economic status and the major determinants of breast cancer risk, failed to account for the observed association (multivariate relative risk = 1.84 for ever use and 2.04 > 2 year use). Possible explanations for these findings and for their apparent discrepancy with some American data are discussed in terms of different baseline incidence of breast cancer in the two populations, and hence of potential baseline differences in availability of endogenous serum oestrogens. Nonetheless, the results of this study should be interpreted cautiously and viewed as a further contribution to a topic still open to debate.

AB - The relationship between use of non-contraceptive oestrogens and risk of breast cancer was investigated using data from a hospital-based case-control study from Northern Italy. This study covered 1,108 patients with histologically confirmed breast cancers and 1,281 control subjects with a large spectrum of acute conditions unrelated to any of the known or suspected risk factors for breast cancer. Compared with 'never-users', the age-adjusted relative risk for 'ever-users' was 1.93 (95% confidence interval = 1.35-2.75). The risk increased with duration of use (relative risk = 2.08 for over 2 years), but was unrelated to time elapsed since first or last use. Allowance for a large number of identified potential confounding factors, including indicators of socio-economic status and the major determinants of breast cancer risk, failed to account for the observed association (multivariate relative risk = 1.84 for ever use and 2.04 > 2 year use). Possible explanations for these findings and for their apparent discrepancy with some American data are discussed in terms of different baseline incidence of breast cancer in the two populations, and hence of potential baseline differences in availability of endogenous serum oestrogens. Nonetheless, the results of this study should be interpreted cautiously and viewed as a further contribution to a topic still open to debate.

UR - http://www.scopus.com/inward/record.url?scp=0022861747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022861747&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 853

EP - 858

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -